Showing results (31-40 of 599) with videos related to
Sort By:
Pageof 60
Pharmacoeconomics|November 30, 2002
National Institute for Clinical Excellence (NICE): Is economic appraisal working?Adrian Towse, Clive PritchardValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?Adrian Towse, Elisabeth FenwickValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2024
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both PartiesAdrian Towse, Elisabeth FenwickValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 5, 2002
The economics of gene therapy and of pharmacogeneticsPatricia Danzon, Adrian TowseThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 18, 2014
Orphan drugs policies: a suitable case for treatmentMichael Drummond, Adrian TowseFrontiers in Health Services|March 17, 2023
The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimatesBernarda Zamora, Adrian TowseHealth Affairs (Project Hope)|July 10, 2018
Membership In Seguro Popular In Mexico Linked To A Small Reduction In Catastrophic Health ExpenditureZlatko Nikoloski, Elias MossialosJournal of Health Politics, Policy and Law|June 10, 2005
European health systems reforms: looking backward to see forward?Adam Oliver, Elias MossialosJournal of Health Politics, Policy and Law|June 10, 2005
Plus ça change: health sector reforms in GreeceKonstantina Davaki, Elias MossialosThe International Journal of Health Planning and Management|December 13, 2005
An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United KingdomElias Mossialos, Adam OliverPageof 60